Videos Library
Blueprint for market access: Strategic insights from the regulatory and HTA review process
Related topics:
Pharmaceutical/Biotech, Europe, Market Access & HEOR
Overview
An interactive session exploring the lifecycle of a drug including:
- Comparison of regulatory and HTA agency clinical trial evaluations
- Impact of the label indications on the HTA review process
- HTA opinion on submitted evidence
Speaker
Yin Ho
CEO
Context Matters Inc., USA
Subscribe or unlock this video to download the presentation slides. If you already have an account, please log in.
REMINDER
This is the presenters’ personal opinion and does not necessarily represent true facts, the official views or policy of their organisation, nor the views of Evidence Life Science.
Sponsor
